ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signaling

作者：Masuda Tetsuro; Endo Motoyoshi^*; Yamamoto Yutaka; Odagiri Haruki; Kadomatsu Tsuyoshi; Nakamura Takayuki; Tanoue Hironori; Ito Hitoshi; Yugami Masaki; Miyata Keishi; Morinaga Jun; Horiguchi Haruki; Motokawa Ikuyo; Terada Kazutoyo; Morioka Masaki Suimye; Manabe Ichiro; Iwase Hirotaka; Mizuta Hiroshi; Oike Yuichi

来源：Scientific Reports, 2015, 5(1): 9170.

DOI：10.1038/srep09170

Bone metastasis of breast cancer cells is a major concern, as it causes increased morbidity and mortality in patients. Bone tissue-derived CXCL12 preferentially recruits breast cancer cells expressing CXCR4 to bone metastatic sites. Thus, understanding how CXCR4 expression is regulated in breast cancer cells could suggest approaches to decrease bone metastasis of breast tumor cells. Here, we show that tumor cell-derived angiopoietin-like protein 2 (ANGPTL2) increases responsiveness of breast cancer cells to CXCL12 by promoting up-regulation of CXCR4 in those cells. In addition, we used a xenograft mouse model established by intracardiac injection of tumor cells to show that ANGPTL2 knockdown in breast cancer cells attenuates tumor cell responsiveness to CXCL12 by decreasing CXCR4 expression in those cells, thereby decreasing bone metastasis. Finally, we found that ANGPTL2 and CXCR4 expression levels within primary tumor tissues from breast cancer patients are positively correlated. We conclude that tumor cell-derived ANGPTL2 may increase bone metastasis by enhancing breast tumor cell responsiveness to CXCL12 signaling through up-regulation of tumor cell CXCR4 expression. These findings may suggest novel therapeutic approaches to treat metastatic breast cancer.

• 出版日期2015-3-16